Jocelyn Arel is a partner in the firm’s Technology Companies practice and leads the firm’s Special Purpose Acquisition Companies (“SPAC”) practice.

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Jocelyn Arel is a pioneer in the U.S. for her innovative work for clients on SPACs, with nearly two decades of successful SPACs transactions under her belt. Ms. Arel advises clients in all aspects of the SPAC lifecycle, including the formation and structuring sponsor entities, representing SPACs and SPAC sponsors in initial public offerings (“IPOs”); representing operating companies, their investors and SPACs in business combinations, or “SIPO transactions”; structuring the debt and equity financing transactions that are often needed to facilitate the closing of SIPO transactions; and, advising investors in both SPAC IPOs and SIPO transactions. In addition to her extensive knowledge of the legal issues related to SPACs, Ms. Arel has a deep understanding of the business, financial and marketing issues that affect the success of SPACs.

In addition to her leadership in the SPAC market, Ms. Arel represents clients in a wide range of capital market transactions, including initial and follow-on public offerings, private placements of debt and equity, alternative financing and 144A transactions, mergers and acquisitions and joint ventures. She has extensive experience in cross-border financings and acquisitions, as well as in providing advice on other U.S.-based activities for companies headquartered in Canada. A significant portion of Ms. Arel’s practice includes counseling clients on ongoing reporting requirements of public companies, corporate governance matters and various other matters affecting public companies, their officers and directors. She also has considerable expertise in structuring and executing secondary sales and other private liquidity programs for private companies and their investors.

A selection of Ms. Arel’s recent representations include:

Representative Matters

REFERENZMANDATE

代表事项

SPAC IPOs and deSPAC Transactions
  • Vy Global Growth in its $500 million SPAC IPO; 
  • Qell Acquisition Corp. in its $330 million SPAC IPO; 
  • Ribbit LEAP, Ltd. in its $350 million SPAC IPO; 
  • Prime Impact Acquisition I in its $300 million SPAC IPO;
  • one in its $200 million SPAC IPO;
  • Cerevel Therapeutics in its pending business combination with Arya Sciences Acquisition Corp II;
  • PTK Acquisition Corp. in its $100 million SPAC IPO;
  • Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. in its $135.7 million SPAC IPO;
  • Open Lending LLC in its business combination with Nebula Acquisition Corp;
  • Immatics in its business combination with Arya Sciences Acquisition Corp.;
  • Investors in connection with the Diamond Eagle Acquisition Corp.’s business combination with DraftKings, Inc. and SBTech Global (Limited);
  • Investors in connection with Exela Technologies, formerly known as Quinpario Acquisition Corp. 2, roll-up business combination with SourceHOV Holdings, Inc. and Novitex Holdings, Inc.;
  • BiomX in its business combination with Chardan Healthcare Acquisition Corp.;
  • Representation of TKK Symphony Acquisition Corp in connection with its tender offer and business combination with Glory Star New Media Holdings Group Ltd.;
  • Yatra Online, Inc. in its business combination with Terrapin 3 Acquisition Corporation; and
  • A leading investment bank in connection with the business combination of Boulder Specialty Brands, Inc. with GFA Holdings, Inc, and related PIPE financing, and secured debt financings.
Capital Markets and Mergers & Acquisitions
  • Yatra Online, Inc. (NASDAQ: YTRA) in its proposed merger agreement with Ebix, Inc. (NASDAQ: EBIX) where Ms. Arel structured s bespoke security using preferred stock that had common stock characteristics while featuring an embedded put right for Yatra shareholders. The deal was recognized for its unique structure by the Financial Times Innovative Lawyers North America.
  • WisdomTree Investments, Inc. in its acquisition of ETF Securities’ European commodities platform for $18 billion, $150 million Convertible debt deal and Series A Preferred Stock financing of Securrency, Inc.
  • Compass Therapeutics, in its $60 million private placement and reverse merger transaction with Olivia Ventures, Inc.
  • Investors in PIPE transactions for Interpace Biosciences, Inc., Novavax, Inc. and Verona Pharma PLC.
  • Investors in IPOs including Facebook, Zynga, Groupon, Twitter, Alibaba, JD.com, Spotify, Funding Circle, Xiaomi, Greensky, LendingClub, Dada, Snap and Nexus Limited.
  • Issuers and investors in private tender offers in private technology companies.
Professional Experience

Prior to joining Goodwin, Ms. Arel was a partner in the Business Practice Group at Testa, Hurwitz & Thibeault, where she was co-chair of the Corporate Finance and Securities Group and member of the Canadian Initiative. Before that, she was an associate in the New York office of Skadden, Arps, Slate, Meagher & Flom.

Recognition

Ms. Arel has been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business. While attending law school, she was a member of the American University Law Review.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 1989
American University Washington College of Law

(cum laude)

M.Sc., 1986
The London School of Economics and Political Science
B.A., 1985
Fordham University

Admissions

Bar

New York
Massachusetts
Profile Image
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师